Instituto Rosenbusch SA de Biologia Experimental Agropecuaria (ROSEm)

Currency in ARS
159.500
+1.000(+0.63%)
Closed·

ROSEm Income Statement

Period Ending:
2016
31/12
2017
31/12
2018
31/12
2019
31/12
2020
31/12
2021
31/12
2022
31/12
2023
31/12
2024
31/12
2025
31/12
Other Operating Expenses, Total Growth
R&D Expenses
Selling General & Admin Expenses
Other Operating Expenses
aa.aaaa.aaaa.aaaa.aaaa.aa+99.37%+183.65%+154.04%-9.7%+22.36%
aa.aaaa.aaaa.aaaa.aaaa.aa-----
aa.aaaa.aaaa.aaaa.aaaa.aa397.231,054.242,517.062,428.22,448.68
aa.aaaa.aaaa.aaaa.aaaa.aa-10.0144.11273.1791.5634.37
* In Millions of ARS (except for per share items)

FAQ

What was Instituto Rosenbusch’s revenue at year end?

At the end of the last reported fiscal year, Instituto Rosenbusch (ROSEm) recorded total revenue of 6,403.594 million ARS.

How much revenue did Instituto Rosenbusch report in the most recent quarter?

In its most recent quarterly earnings report, Instituto Rosenbusch posted revenue of 2,130.381 million ARS.

What was Instituto Rosenbusch’s net income for the year?

For the full year, Instituto Rosenbusch reported net income of -4,597.736 million ARS.

How much net income did Instituto Rosenbusch post in the last quarter?

In the most recent quarter, Instituto Rosenbusch (ROSEm) posted net income of -1,353.546 million ARS.

What was Instituto Rosenbusch’s gross profit for the year?

Gross profit for the year was reported at -286.034 million ARS.

How much gross profit did Instituto Rosenbusch generate last quarter?

Instituto Rosenbusch recorded gross profit of 591.751 million ARS in its latest quarterly report.

What was Instituto Rosenbusch’s annual operating income?

For the full year, Instituto Rosenbusch (ROSEm) reported operating income of -3,369.076 million ARS.

What was Instituto Rosenbusch’s operating income last quarter?

Quarterly operating income was -860.071 million ARS.

What was Instituto Rosenbusch’s quarterly EBITDA?

In the latest quarter, EBITDA was reported at -804.346 million ARS.

What was the quarter-over-quarter change in EBITDA for Instituto Rosenbusch?

EBITDA changed by 25.573% million ARS compared to the last quarter.

What is Instituto Rosenbusch’s most recent gross profit margin?

The latest reported gross profit margin for Instituto Rosenbusch (ROSEm) is 27.777% million ARS.

What is Instituto Rosenbusch’s most recent net income margin?

Net income margin based on recent financials is -63.535% million ARS.

What is Instituto Rosenbusch’s most recent EBIT margin?

Instituto Rosenbusch reported an EBIT margin of -40.372% million ARS based on current figures.

How did Instituto Rosenbusch’s revenue change compared to the previous quarter?

Revenue changed by 21.930% million ARS compared to the prior quarter.

What was the quarter-over-quarter change in gross profit for Instituto Rosenbusch?

In the latest quarter, gross profit changed by 242.610% million ARS from the previous quarter.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.